In the latest edition of The Cancer Letter, NBCC’s Chief Programs Officer Michelle Tregear expanded upon NBCC’s recent statement on […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
In the latest edition of The Cancer Letter, NBCC’s Chief Programs Officer Michelle Tregear expanded upon NBCC’s recent statement on […]
This week, the US Food and Drug Administration (FDA) announced the removal of class-wide boxed warnings related to risks of […]
In The Lever, National Breast Cancer Coalition (NBCC) President Fran Visco commented on the Food and Drug Administration’s (FDA) drug […]
On October 24, 2025, NBCC’s Chief Policy Officer Melanie Wyne delivered the following remarks at the Democratic Women’s Caucus Shadow […]
On October 20, 2025, NBCC’s Chief Programs Officer Michelle Tregear submitted the following letter to the U.S. Food and Drug […]
